07:38 AM EDT, 03/21/2025 (MT Newswires) -- Conavi Medical ( CNVIF ) a medical device company developing imaging technologies to guide cardiovascular procedures, on Friday said its previously announced public offering will now proceed as an offering of securities. The size of the offering and pricing of securities is yet to be determined.

Proceeds will be used to develop Conavi's Novasight 3.0 technology, with the aim of submitting a 510(k) clearance application to the U.S. Food and Drug Administration in the third quarter of this year.

The offering is expected to close by March 31.